Europeanhhm

Caristo Diagnostics AI Technology Chosen by Heart & Lung Health for Nationwide Early Diagnosis of Coronary Artery Disease in the UK

Tuesday, March 19, 2024

The collaboration between Heart & Lung Health (HLH) and Caristo Diagnostics signifies a groundbreaking advancement in cardiovascular diagnostics and patient care in the UK. Through this partnership, HLH, a network of specialized cardiothoracic radiologists, will integrate Caristo's innovative CaRi-Heart® AI technology into its cardiac health assessment services across multiple locations in the country.

CaRi-Heart® AI technology, developed based on research originating at the University of Oxford, introduces a revolutionary approach to assessing coronary artery disease (CAD) risk. By detecting coronary inflammation, a previously undetected risk factor in routine coronary computed tomography angiography (CCTA) scans, CaRi-Heart aims to improve risk stratification and identify patients at heightened risk of cardiac events, even among those traditionally considered low-risk.

The integration of CaRi-Heart into HLH's cardiac health check package expands the organization's capabilities beyond its established lung health screening services. This strategic move positions HLH as a comprehensive provider of cardiovascular and pulmonary diagnostics, catering to the evolving needs of patients and healthcare providers.

Patients screened with CaRi-Heart will receive personalized care from their referring clinicians, including consultant cardiologists or family doctors. These clinicians will interpret the CaRi-Heart assessment results and implement appropriate management strategies based on identified cardiac risks. By facilitating early diagnosis and intervention, CaRi-Heart has the potential to improve patient outcomes and reduce the incidence of cardiac events among high-risk individuals.

Overall, the collaboration between HLH and Caristo Diagnostics represents a significant step forward in preventive medicine and cardiovascular care in the UK. By leveraging cutting-edge AI technology to enhance cardiac risk assessment, this partnership aims to mitigate the burden of cardiovascular disease and improve the overall health and well-being of patients across the country.

Source: prnewswire.com

 

 

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024